Replies to post #768 on Armata Pharmaceuticals, Inc. (ARMP)

[BoneUp]

Per the 10-K, they have cash to last them through April; another highly dilutive financing on terrible terms coming up...


As of December 31, 2016, the Company had cash and cash equivalents of $5.7 million. Management believes that its existing resources will be sufficient to fund its planned operations through mid-April 2017.